2026-01-26 - Analysis Report
**1. Company Overview**
IBM is an American multinational technology and consulting company that offers a wide range of products and services in the fields of hardware, software, and services.

**2. Return Rate Comparison**

* Cumulative return of review stock (IBM): 152.27%
* Cumulative return of comparison stock (S&P 500, VOO): 126.41%
* Divergence: 25.10 (current) / 53.70 (max) / -80.00 (min)
* Relative divergence: 78.60%

The review stock (IBM) has outperformed the comparison stock (S&P 500) with a difference in cumulative return of 25.10.

**3. Alpha, Beta Analysis**

| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018 | -19.0% | 24.8% | -31.0% | 0.9 | 101.6B |
| 2017-2019 | -20.0% | 24.8% | -46.0% | 1.0 | 119.8B |
| 2018-2020 | -12.0% | 37.5% | -36.0% | 1.0 | 112.5B |
| 2019-2021 | 19.0% | 37.5% | -46.0% | 0.9 | 124.9B |
| 2020-2022 | 17.0% | 37.5% | 10.0% | 0.8 | 131.7B |
| 2021-2023 | 53.0% | 15.2% | 32.0% | 0.5 | 152.9B |
| 2022-2024 | 81.0% | 15.7% | 51.0% | 0.6 | 205.5B |
| 2023-2025 | 137.0% | 19.1% | 62.0% | 0.7 | 276.9B |

The review stock (IBM) has shown significant fluctuations in its Alpha and Beta values over the years.

**4. Stock Price Fluctuations**

* Close: $292.44
* 5-day SMA: $296.33
* 20-day SMA: $300.51
* 60-day SMA: $303.56

The review stock (IBM) has experienced a recent decline in its stock price, with its current price being below its 5-day, 20-day, and 60-day moving averages.

**5. RSI, PPO Index Indicators**

* Market Risk Indicator (MRI): 0.70
* RSI: 50.51
* PPO: -0.35
* Hybrid Signal: Buy (Cash 0%)
* Risk Level: Medium
* Recent (20 days) relative divergence change: -2.80 (worsening)
* 7-day Rank change: 0 (flat)
* 7-day Dynamic Expected Return change: 0.00 (flat)
* Expected Return (%): -5.90%

The review stock (IBM) has a medium risk level according to the Market Risk Indicator (MRI) and is currently in a neutral position according to its RSI and PPO values.

**6. Recent News & Significant Events**

* [2026-01-21] Buy The Dip In IBM Stock? - Forbes
* [2026-01-21] Dear IBM Stock Fans, Mark Your Calendars for January 28 - Barchart.com
* [2026-01-22] Should You 'Buy' or 'Sell' IBM Stock Ahead of Q4 Earnings? - Yahoo Finance
* [2026-01-20] Dow's 888-point fall led by losses in 3M, IBM stocks - MSN
* [2026-01-21] Should You Buy IBM Stock After Yesterdayâ€™s Drop? - Trefis
* [2026-01-17] 3 Reasons to Buy IBM Stock Right Now - The Motley Fool

Recent news and significant events have highlighted the potential for a rebound in IBM's stock price.

**7. Analyst Opinions**

Analyst Consensus:
* Key: Buy
* Mean (1=StrongBuy~5=Sell): 2.38 (~Buy)
* Opinions: 19
* Target Price (avg/high/low): 305.16 / 375.00 / 210.00

Analysts have a buy recommendation for IBM stock, with an average target price of 305.16.

**8. Recent Earnings Analysis**

| Date | EPS | Revenue |
|---|---:|---:|
| 2025-10-23 | 1.87 | 16.33 B$ |
| 2025-07-24 | 2.36 | 16.98 B$ |
| 2025-04-24 | 1.14 | 14.54 B$ |
| 2024-10-30 | -0.36 | 14.97 B$ |
| 2025-10-23 | -0.36 | 14.97 B$ |

IBM's EPS and revenue have experienced fluctuations over the recent quarters, with a notable decline in earnings.

**9. Financial Information**

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $16.33B | 57.31% |
| 2025-06-30 | $16.98B | 58.77% |
| 2025-03-31 | $14.54B | 55.23% |
| 2024-12-31 | $17.55B | 59.47% |
| 2024-09-30 | $14.97B | 56.26% |

IBM's revenue and profit margin have been experiencing fluctuations over the recent quarters.

**Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $27.91B | 6.25% |
| 2025-06-30 | $27.51B | 7.98% |
| 2025-03-31 | $26.88B | 3.92% |
| 2024-12-31 | $27.31B | 10.67% |
| 2024-09-30 | $24.45B | -1.35% |

IBM's equity and ROE have experienced fluctuations over the recent quarters, with a notable decline in earnings.

**Comprehensive Analysis**

Based on the analysis, IBM stock has experienced fluctuations in its return rate, Alpha and Beta values, and financial metrics. While analysts have a buy recommendation for the stock, its recent earnings have experienced a decline. Therefore, investors should exercise caution when considering IBM stock.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.